(Total Views: 253)
Posted On: 04/04/2017 12:17:06 PM
Post# of 15624
what should the market cap be of a MMJ biopharma with a breakthrough psoriasis drug coming to market in coming months?
a treatment that is disruptive, in that it is as/( likely more?) effective than all current treatments - the biologics- that have serious, severe side effects and are wildly expensive, (20-50k/yr)
so, OWC's cream is safer,( perhaps if you slathered your whole body in OWC's cream you'd get tired?)
-as, or more effective, and definitely more affordable.
the product will be internationally available, in the US in legal states
and they are beginning phase 1 clinical trials later this year so, I believe, as to also go the FDA route,
so eventually to move the product into the pharmacy where it could also be prescribed and covered by insurance.
with just the psoriasis drug, I put a MC at least 3x where we are now,
roll in their other IP, tablet coming also this year, myeloma studies,
the ETF, and world movement towards legalization and MMJ acceptance,
by 2018 imo a $10 target is conservative.
I'm waiting for it.
a treatment that is disruptive, in that it is as/( likely more?) effective than all current treatments - the biologics- that have serious, severe side effects and are wildly expensive, (20-50k/yr)
so, OWC's cream is safer,( perhaps if you slathered your whole body in OWC's cream you'd get tired?)
-as, or more effective, and definitely more affordable.
the product will be internationally available, in the US in legal states
and they are beginning phase 1 clinical trials later this year so, I believe, as to also go the FDA route,
so eventually to move the product into the pharmacy where it could also be prescribed and covered by insurance.
with just the psoriasis drug, I put a MC at least 3x where we are now,
roll in their other IP, tablet coming also this year, myeloma studies,
the ETF, and world movement towards legalization and MMJ acceptance,
by 2018 imo a $10 target is conservative.
I'm waiting for it.
(3)
(0)
